Real-world experience with cannabidiol as add-on treatment in drug-resistant epilepsy-Reference-Cited by-同舟云学术

Real-world experience with cannabidiol as add-on treatment in drug-resistant epilepsy

Published:2023-10 Issue: Volume:111 Page:39-41
ISSN:1059-1311
Container-title:Seizure: European Journal of Epilepsy
language:en
Short-container-title:Seizure: European Journal of Epilepsy

Author:

Vicino Walter,Muccioli Lorenzo^ORCID,Pondrelli Federica,Licchetta Laura,Stipa Carlotta,Mostacci Barbara,Di Vito Lidia,Ferri Lorenzo^ORCID,Cancellerini Chiara,Soldà Martina,Tinuper Paolo,Bisulli Francesca

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference10 articles.

1. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: results of a long-term open-label extension trial;Patel;Epilepsia,2021

2. Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond dravet syndrome and lennox-gastaut syndrome;Lattanzi;CNS Drugs,2021

3. Two-center experience of cannabidiol use in adults with Dravet syndrome;Silvennoinen;Seizure,2021

4. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome;Lattanzi;Drugs Today (Barc),2019

5. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial;Thiele;Lancet,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series;CNS & Neurological Disorders - Drug Targets;2024-06-21

2. Cannabidiol: metabolism and clinical efficacy in epileptic patients;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03